Giuseppe Curigliano, MD, PhD

European Society of Medical Oncology

Latest Videos

Experts discuss personalized adjuvant CDK4/6 inhibitor therapy for breast cancer in a professional conference setting.

Conferences

06/08/2026

How to Select a CDK4/6 Inhibitor in Early or Metastatic Breast Cancer

Giuseppe Curigliano, MD, PhDArya Mariam Roy, MD